Published April 16, 2025 | Version v1
Journal article Open

Pigmented Villonodular Synovitis of The Knee Joint: Diagnosis, Management and Summary of Tenosynovial Giant Cell Tumors: A Rare Case Report

  • 1. International Journal of Medical Science and Advanced Clinical Research (IJMACR)

Description

Abstract

Introduction: Pigmented villonodular synovitis (PVNS) is a rare, benign, but potentially locally aggressive and recurrent condition characterized by synovial proliferation and hemosiderin deposition inside the joints, tendon sheaths, and bursae. It usually affects the large joints such as hip, knee, and ankle. Localised pigmented villonodular synovitis {PVNS} of the knee is rare diagnosis, with clinical signs and symptoms mimicking meniscal damage or other common knee injuries. 

Case Presentation: We report a case of PVNS of the knee joint in a 39-year-old female which was treated by arthroscopic subtotal synovectomy as a first stage surgery after which patient was planned for total synovectomy and postoperative radiotherapy. This case highlights the clinical presentation of this rare disorder and emphasizes its consideration as a differential diagnosis in our setup when dealing with non-traumatic persistent knee pain and swelling.

Conclusion: Pigmented villonodular synovitis demonstrates a locally destructive process but is rarely fatal. PVNS is primarily a disease of quality of life as it can lead to difficulty with activities of daily living and an overall decrease in quality of life. The clinical presentation of one case found in our region is described. Patients usually present with insidious onset joint swelling associated with pain that mimics joint effusion. Joint pain subsequently supervenes, but the swelling is disproportionate to the degree of pain. The pain is mild and of insidious onset, and it progressively worsens and frequently is accompanied by decreased range of motion and sometimes locking of the joint. We recommend that PVNS should be included as a differential diagnosis when evaluating a young adult with non-traumatic persistent knee pain and swelling

Files

AKASH.pdf

Files (1.1 MB)

Name Size Download all
md5:8e42ea17968bb33e4da4469cebc40a51
1.1 MB Preview Download

Additional details

References

  • 1. Sullivan CJ, Eustace SJ, Kavanagh EC. Pigmented villonodular synovitis of the hip joint: three cases demonstrating characteristic MRI features. Radiol Case Rep. 24 Jun 2020;15(8):1335–8 PMID: 32617126; PMCID: PMC7322487. doi:10.1016/j.radcr.2020.05.067. 2. Fecek C, Carter KR. Pigmented villonodular synovitis. StatPearls [Internet], Treasure Island (FL): StatPearls Publishing; 7 Nov 2021. 2022 Jan–. PMID: 31751040 3. Burton TM, Ye X, Parker ED, Bancroft T, Healey J. Burden of Illness Associated with Tenosynovial Giant Cell Tumors. Clin Ther. 2018 Apr;40(4):593-602.e1. [PMC free article] [PubMed] 4. Staals EL, Ferrari S, Donati DM, Palmerini E. Diffuse-type tenosynovial giant cell tumour: Current treatment concepts and future perspectives. Eur J Cancer. 2016 Aug;63:34-40. [PubMed] 5. West RB, Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K, Zhu S, Marinelli RJ, De Luca A, Downs-Kelly E, Goldblum JR, Corless CL, Brown PO, Gilks CB, Nielsen TO, Huntsman D, van de Rijn M. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):690-5. [PMC free article] [PubMed] 6. Xie GP, Jiang N, Liang CX, Zeng JC, Chen ZY, Xu Q, Qi RZ, Chen YR, Yu B. Pigmented villonodular synovitis: a retrospective multicenter study of 237 cases. PLoS One. 2015;10(3):e0121451. [PMC free article] [PubMed] 7. Mastboom MJL, Verspoor FGM, Verschoor AJ, Uittenbogaard D, Nemeth B, Mastboom WJB, Bovée JVMG, Dijkstra PDS, Schreuder HWB, Gelderblom H, Van de Sande MAJ., TGCT study group. Higher incidence rates than previously known in tenosynovial giant cell tumors. Acta Orthop. 2017 Dec;88(6):688-694. [PMC free article] [PubMed] 8. Brahmi M, Vinceneux A, Cassier PA. Current Systemic Treatment Options for Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis: Targeting the CSF1/CSF1R Axis. Curr Treat Options Oncol. 2016 Feb;17(2):10. [PubMed] 9. Zhao L, Zhou K, Hua Y, Li Y, Mu D. Multifocal pigmented villonodular synovitis in a child: A case report. Medicine (Baltimore). 2016 Aug;95(33): e4572. [PMC free article] [PubMed] 10. Frassica FJ, Bhimani MA, McCarthy EF, Wenz J. Pigmented villonodular synovitis of the hip and knee. Am Fam Physician. 1999 Oct 01;60(5):1404-10; discussion 1415. [PubMed] 11. Al Farii H, Zhou S, Turcotte R. The surgical outcome and recurrence rate of tenosynovial giant cell tumor in the elbow: a literature review. J Shoulder Elbow Surg. 2019 Sep;28(9):1835-1840. [PubMed] 12. Ramesh B, Shetty S, Bastawrous SS. Pigmented villonodular synovitis of the knee in a patient on oral anticoagulation therapy: a case report. J Med Case Rep. 2009 Nov 13;3:121. [PMC free article] [PubMed] 13. Houdek MT, Scorianz M, Wyles CC, Trousdale RT, Sim FH, Taunton MJ. Long-term outcome of knee arthroplasty in the setting of pigmented villonodular synovitis. Knee. 2017 Aug;24(4):851-855. [PubMed]